{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:42:07Z","timestamp":1792194127097,"version":"4.4.0"},"reference-count":97,"publisher":"BMFH Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.12938\/bmfh.2022-009","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T22:10:12Z","timestamp":1648505412000},"page":"94-102","source":"Crossref","is-referenced-by-count":21,"title":["The role of respiratory microbiota in the protection against viral diseases: respiratory commensal bacteria as next-generation probiotics for COVID-19"],"prefix":"10.12938","volume":"41","author":[{"given":"Bruno G. N.","family":"ANDRADE","sequence":"first","affiliation":[{"name":"Adapt Centre, Munster Technological University (MTU),              T12 P928 Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael R. C.","family":"CUADRAT","sequence":"additional","affiliation":[{"name":"Max Delbr\u00fcck Center for Molecular Medicine in the              Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB),              13125 Berlin, Germany"},{"name":"Department of Molecular Epidemiology, German Institute              of Human Nutrition Potsdam-Rehbr\u00fccke, 14558 Nuthetal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Raya","family":"TONETTI","sequence":"additional","affiliation":[{"name":"Laboratory of Immunobiotechnology, Reference Centre for              Lactobacilli (CERELA-CONICET), 4000 Tucum\u00e1n, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"KITAZAWA","sequence":"additional","affiliation":[{"name":"Food and Feed Immunology Group, Laboratory of Animal              Food Function, Graduate School of Agricultural Science, Tohoku University, 1-1              Amamiya-machi, Tsutsumidori, Aoba-ku, Sendai, Miyagi 981-8555,            Japan"},{"name":"Livestock Immunology Unit, International Education and              Research Center for Food and Agricultural Immunology (CFAI), Graduate School of              Agricultural Science, Tohoku University, 1-1 Amamiya-machi, Tsutsumidori, Aoba-ku,              Sendai, Miyagi 981-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"VILLENA","sequence":"additional","affiliation":[{"name":"Laboratory of Immunobiotechnology, Reference Centre for              Lactobacilli (CERELA-CONICET), 4000 Tucum\u00e1n, Argentina"},{"name":"Food and Feed Immunology Group, Laboratory of Animal              Food Function, Graduate School of Agricultural Science, Tohoku University, 1-1              Amamiya-machi, Tsutsumidori, Aoba-ku, Sendai, Miyagi 981-8555,            Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5076","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Huffnagle              GB, Dickson              RP, Lukacs              NW. 2017.            The respiratory tract microbiome and lung inflammation: a two-way            street. Mucosal Immunol 10:            299\u2013306.","DOI":"10.1038\/mi.2016.108"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wacharapluesadee              S, Tan              CW, Maneeorn              P, Duengkae              P, Zhu              F, Joyjinda              Y, Kaewpom              T, Chia              WN, Ampoot              W, Lim              BL,                Worachotsueptrakun              K, Chen              VC, Sirichan              N,                Ruchisrisarod              C, Rodpan              A,                Noradechanon              K, Phaichana              T, Jantarat              N,                Thongnumchaima              B, Tu              C, Crameri              G, Stokes              MM,                Hemachudha              T, Wang              LF. 2021.            Evidence for SARS-CoV-2 related coronaviruses circulating in bats and            pangolins in Southeast Asia. Nat Commun12: 972.","DOI":"10.1038\/s41467-021-21768-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Dickson              I. 2020.            Organoids demonstrate gut infection by SARS-CoV-2.            Nat Rev Gastroenterol Hepatol 17: 383.","DOI":"10.1038\/s41575-020-0317-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wang              Y, Liu              S, Liu              H, Li              W, Lin              F, Jiang              L, Li              X, Xu              P, Zhang              L, Zhao              L, Cao              Y, Kang              J, Yang              J, Li              L, Liu              X, Li              Y, Nie              R, Mu              J, Lu              F, Zhao              S, Lu              J, Zhao              J. 2020.            SARS-CoV-2 infection of the liver directly contributes to hepatic            impairment in patients with COVID-19. J Hepatol 73: 807\u2013816.","DOI":"10.1016\/j.jhep.2020.05.002"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Marshall              M. 2020.            How COVID-19 can damage the brain.            Nature 585: 342\u2013343.","DOI":"10.1038\/d41586-020-02599-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Falahi              S, Kenarkoohi              A. 2020.            COVID-19 reinfection: prolonged shedding or true            reinfection? New Microbes New Infect 38: 100812.","DOI":"10.1016\/j.nmni.2020.100812"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Greenhalgh              T, Jimenez              JL, Prather              KA, Tufekci              Z, Fisman              D, Schooley              R. 2021.            Ten scientific reasons in support of airborne transmission of            SARS-CoV-2. Lancet 397:            1603\u20131605.","DOI":"10.1016\/S0140-6736(21)00869-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kumpitsch              C, Koskinen              K, Sch\u00f6pf              V,                Moissl-Eichinger              C. 2019.            The microbiome of the upper respiratory tract in health and            disease. BMC Biol 17:            87.","DOI":"10.1186\/s12915-019-0703-z"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Round              JL, Mazmanian              SK. 2009.            The gut microbiota shapes intestinal immune responses during health and            disease. Nat Rev Immunol 9:            313\u2013323.","DOI":"10.1038\/nri2515"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Vayssier-Taussat              M, Albina              E, Citti              C, Cosson              JF, Jacques              MA, Lebrun              MH, Le Loir              Y, Ogliastro              M, Petit              MA, Roumagnac              P, Candresse              T. 2014.            Shifting the paradigm from pathogens to pathobiome: new concepts in the            light of meta-omics. Front Cell Infect            Microbiol 4: 29.","DOI":"10.3389\/fcimb.2014.00029"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Clark              SE. 2020.            Commensal bacteria in the upper respiratory tract regulate susceptibility            to infection. Curr Opin Immunol 66:            42\u201349.","DOI":"10.1016\/j.coi.2020.03.010"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Elgamal              Z, Singh              P, Geraghty              P. 2021.            The upper airway microbiota, environmental exposures, inflammation, and            disease. Medicina (Kaunas) 57:            57.","DOI":"10.3390\/medicina57080823"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Khan              R, Petersen              FC, Shekhar              S. 2019.            Commensal bacteria: an emerging player in defense against respiratory            pathogens. Front Immunol 10:            1203.","DOI":"10.3389\/fimmu.2019.01203"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hawkes              MT, Lee              BE, Kanji              JN, Zelyas              N, Wong              K, Barton              M, Mukhi              S, Robinson              JL. 2021.            Seasonality of respiratory viruses at northern latitudes.            JAMA Netw Open 4:            e2124650\u2013e2124650.","DOI":"10.1001\/jamanetworkopen.2021.24650"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. M\u00e4kinen              TM, Juvonen              R, Jokelainen              J, Harju              TH, Peitso              A, Bloigu              A,                Silvennoinen-Kassinen              S, Leinonen              M, Hassi              J. 2009.            Cold temperature and low humidity are associated with increased            occurrence of respiratory tract infections. Respir            Med 103: 456\u2013462.","DOI":"10.1016\/j.rmed.2008.09.011"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fendrick              AM, Monto              AS,                Nightengale              B, Sarnes              M. 2003.            The economic burden of non-influenza-related viral respiratory tract            infection in the United States. Arch Intern Med 163: 487\u2013494.","DOI":"10.1001\/archinte.163.4.487"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Schroth              J,                Thiemermann              C, Henson              SM. 2020.            Senescence and the aging immune system as major drivers of chronic kidney            disease. Front Cell Dev Biol 8:            564461.","DOI":"10.3389\/fcell.2020.564461"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mayor              S. 2010.            Acute respiratory infections are world\u2019s third leading cause of            death. BMJ 341: c6360.","DOI":"10.1136\/bmj.c6360"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Dobson              R. 2007.            Flu costs the US $90bn a year, report shows.            BMJ 334: 1134.","DOI":"10.1136\/bmj.39226.597951.DB"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Humphreys              C. 2020.          19-Intestinal permeability. Textbook of Natural Medicine, 5th ed. Churchill Livingstone,          St. Louis, pp. 166\u2013177.e164.","DOI":"10.1016\/B978-0-323-43044-9.00019-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. de Steenhuijsen Piters              WA, Huijskens              EG, Wyllie              AL, Biesbroek              G, van den                Bergh              MR, Veenhoven              RH, Wang              X, Trzci\u0144ski              K, Bonten              MJ, Rossen              JW, Sanders              EA, Bogaert              D. 2016.            Dysbiosis of upper respiratory tract microbiota in elderly pneumonia            patients. ISME J 10:            97\u2013108.","DOI":"10.1038\/ismej.2015.99"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Edouard              S, Million              M, Bachar              D, Dubourg              G, Michelle              C, Ninove              L, Charrel              R, Raoult              D. 2018.            The nasopharyngeal microbiota in patients with viral respiratory tract            infections is enriched in bacterial pathogens. Eur J Clin            Microbiol Infect Dis 37:            1725\u20131733.","DOI":"10.1007\/s10096-018-3305-8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Biesbroek              G,                Tsivtsivadze              E, Sanders              EA, Montijn              R, Veenhoven              RH, Keijser              BJ, Bogaert              D. 2014.            Early respiratory microbiota composition determines bacterial succession            patterns and respiratory health in children. Am J Respir Crit            Care Med 190: 1283\u20131292.","DOI":"10.1164\/rccm.201407-1240OC"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Bosch              AATM, Levin              E, van Houten              MA, Hasrat              R, Kalkman              G, Biesbroek              G, de Steenhuijsen                Piters              WAA, de Groot              PCM, Pernet              P, Keijser              BJF, Sanders              EAM, Bogaert              D. 2016.            Development of upper respiratory tract microbiota in infancy is affected            by mode of delivery. EBioMedicine 9:            336\u2013345.","DOI":"10.1016\/j.ebiom.2016.05.031"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Duijts              L, Jaddoe              VW, Hofman              A, Moll              HA. 2010.            Prolonged and exclusive breastfeeding reduces the risk of infectious            diseases in infancy. Pediatrics 126:            e18\u2013e25.","DOI":"10.1542\/peds.2008-3256"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Teo              SM, Mok              D, Pham              K, Kusel              M, Serralha              M, Troy              N, Holt              BJ, Hales              BJ, Walker              ML, Hollams              E, Bochkov              YA, Grindle              K, Johnston              SL, Gern              JE, Sly              PD, Holt              PG, Holt              KE, Inouye              M. 2015.            The infant nasopharyngeal microbiome impacts severity of lower            respiratory infection and risk of asthma development. Cell Host            Microbe 17: 704\u2013715.","DOI":"10.1016\/j.chom.2015.03.008"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Jakobsson              HE, Jernberg              C, Andersson              AF,                Sj\u00f6lund-Karlsson              M, Jansson              JK, Engstrand              L. 2010.            Short-term antibiotic treatment has differing long-term impacts on the            human throat and gut microbiome. PLoS One5: e9836.","DOI":"10.1371\/journal.pone.0009836"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kaul              D,                Rathnasinghe              R, Ferres              M, Tan              GS, Barrera              A, Pickett              BE, Methe              BA, Das              SR, Budnik              I, Halpin              RA, Wentworth              D, Schmolke              M, Mena              I, Albrecht              RA, Singh              I, Nelson              KE,                Garc\u00eda-Sastre              A, Dupont              CL, Medina              RA. 2020.            Microbiome disturbance and resilience dynamics of the upper respiratory            tract during influenza A virus infection. Nat            Commun 11: 2537.","DOI":"10.1038\/s41467-020-16429-9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Johnson              NP, Mueller              J. 2002.            Updating the accounts: global mortality of the 1918\u20131920 \u201cSpanish\u201d            influenza pandemic. Bull Hist Med 76:            105\u2013115.","DOI":"10.1353\/bhm.2002.0022"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Brundage              JF. 2006.            Interactions between influenza and bacterial respiratory pathogens:            implications for pandemic preparedness. Lancet Infect            Dis 6: 303\u2013312.","DOI":"10.1016\/S1473-3099(06)70466-2"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Charlson              ES, Bittinger              K, Haas              AR,                Fitzgerald              AS, Frank              I, Yadav              A, Bushman              FD, Collman              RG. 2011.            Topographical continuity of bacterial populations in the healthy human            respiratory tract. Am J Respir Crit Care Med 184: 957\u2013963.","DOI":"10.1164\/rccm.201104-0655OC"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Tarabichi              Y, Li              K, Hu              S, Nguyen              C, Wang              X, Elashoff              D, Saira              K, Frank              B, Bihan              M, Ghedin              E, Meth\u00e9              BA, Deng              JC. 2015.            The administration of intranasal live attenuated influenza vaccine            induces changes in the nasal microbiota and nasal epithelium gene expression            profiles. Microbiome 3:            74.","DOI":"10.1186\/s40168-015-0133-2"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Gao              Z, Kang              Y, Yu              J, Ren              L. 2014.            Human pharyngeal microbiome may play a protective role in respiratory            tract infections. Genomics Proteomics            Bioinformatics 12: 144\u2013150.","DOI":"10.1016\/j.gpb.2014.06.001"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Huang              YJ, Lynch              SV. 2011.            The emerging relationship between the airway microbiota and chronic            respiratory disease: clinical implications. Expert Rev Respir            Med 5: 809\u2013821.","DOI":"10.1586\/ers.11.76"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Hasegawa              K, Mansbach              JM, Ajami              NJ, Espinola              JA, Henke              DM, Petrosino              JF, Piedra              PA, Shaw              CA, Sullivan              AF, Camargo              Jr              CA, the MARC-35 Investigators 2016.            Association of nasopharyngeal microbiota profiles with bronchiolitis            severity in infants hospitalised for bronchiolitis. Eur Respir            J 48: 1329\u20131339.","DOI":"10.1183\/13993003.00152-2016"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Fujiogi              M, Goto              T, Yasunaga              H, Fujishiro              J, Mansbach              JM, Camargo              CA              Jr, Hasegawa              K. 2019.            Trends in bronchiolitis hospitalizations in the United States:            2000\u20132016. Pediatrics 144:            144.","DOI":"10.1542\/peds.2019-2614"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Mansbach              JM, Piedra              PA, Teach              SJ, Sullivan              AF, Forgey              T, Clark              S, Espinola              JA, Camargo Jr CA, MARC-30 Investigators 2012.            Prospective multicenter study of viral etiology and hospital length of            stay in children with severe bronchiolitis. Arch Pediatr Adolesc            Med 166: 700\u2013706.","DOI":"10.1001\/archpediatrics.2011.1669"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. DeLaMora              P, Moscona              A. 2012.            Bronchiolitis: too-familiar yet too-mysterious disease of            childhood. Arch Pediatr Adolesc Med 166: 769\u2013770.","DOI":"10.1001\/archpediatrics.2012.157"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Toivonen              L, Camargo              CA              Jr, Gern              JE, Bochkov              YA, Mansbach              JM, Piedra              PA, Hasegawa              K. 2019.            Association between rhinovirus species and nasopharyngeal microbiota in            infants with severe bronchiolitis. J Allergy Clin              Immunol 143: 1925\u20131928.e7.","DOI":"10.1016\/j.jaci.2018.12.1004"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Harata              G, He              F, Hiruta              N, Kawase              M, Kubota              A, Hiramatsu              M, Yausi              H. 2010.            Intranasal administration of <i>Lactobacillus rhamnosus<\/i> GG            protects mice from H1N1 influenza virus infection by regulating respiratory immune            responses. Lett Appl Microbiol 50:            597\u2013602.","DOI":"10.1111\/j.1472-765X.2010.02844.x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Hori              T, Kiyoshima              J, Shida              K, Yasui              H. 2001.            Effect of intranasal administration of <i>Lactobacillus              casei<\/i> Shirota on influenza virus infection of upper respiratory tract in            mice. Clin Diagn Lab Immunol 8:            593\u2013597.","DOI":"10.1128\/CDLI.8.3.593-597.2001"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Izumo              T, Maekawa              T, Ida              M, Noguchi              A, Kitagawa              Y, Shibata              H, Yasui              H, Kiso              Y. 2010.            Effect of intranasal administration of <i>Lactobacillus              pentosus<\/i> S-PT84 on influenza virus infection in mice.            Int Immunopharmacol 10:            1101\u20131106.","DOI":"10.1016\/j.intimp.2010.06.012"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Tonetti              FR, Islam              MA,                Vizoso-Pinto              MG, Takahashi              H, Kitazawa              H, Villena              J. 2020.            Nasal priming with immunobiotic lactobacilli improves the adaptive immune            response against influenza virus. Int            Immunopharmacol 78: 106115.","DOI":"10.1016\/j.intimp.2019.106115"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Zelaya              H, Tada              A,                Vizoso-Pinto              MG, Salva              S, Kanmani              P, Ag\u00fcero              G, Alvarez              S, Kitazawa              H, Villena              J. 2015.            Nasal priming with immunobiotic <i>Lactobacillus rhamnosus<\/i>            modulates inflammation-coagulation interactions and reduces influenza virus-associated            pulmonary damage. Inflamm Res 64:            589\u2013602.","DOI":"10.1007\/s00011-015-0837-6"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Tomosada              Y, Chiba              E, Zelaya              H, Takahashi              T, Tsukida              K, Kitazawa              H, Alvarez              S, Villena              J. 2013.            Nasally administered <i>Lactobacillus rhamnosus<\/i> strains            differentially modulate respiratory antiviral immune responses and induce protection            against respiratory syncytial virus infection. BMC            Immunol 14: 40.","DOI":"10.1186\/1471-2172-14-40"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Villena              J, Chiba              E, Tomosada              Y, Salva              S, Marranzino              G, Kitazawa              H, Alvarez              S. 2012.            Orally administered <i>Lactobacillus rhamnosus<\/i> modulates            the respiratory immune response triggered by the viral pathogen-associated molecular            pattern poly(I:C). BMC Immunol 13:            53.","DOI":"10.1186\/1471-2172-13-53"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Clua              P, Tomokiyo              M, Raya                Tonetti              F, Islam              MA, Garc\u00eda                Castillo              V, Marcial              G, Salva              S, Alvarez              S, Takahashi              H, Kurata              S, Kitazawa              H, Villena              J. 2020.            The role of alveolar macrophages in the improved protection against            respiratory syncytial virus and pneumococcal superinfection induced by the peptidoglycan            of <i>Lactobacillus rhamnosus<\/i> CRL1505.            Cells 9: 9.","DOI":"10.3390\/cells9071653"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Dyer              KD, Drummond              RA, Rice              TA, Percopo              CM, Brenner              TA, Barisas              DA, Karpe              KA, Moore              ML, Rosenberg              HF. 2015.            Priming of the respiratory tract with immunobiotic <i>Lactobacillus              plantarum<\/i> limits infection of alveolar macrophages with recombinant pneumonia            virus of mice (rK2-PVM). J Virol 90:            979\u2013991.","DOI":"10.1128\/JVI.02279-15"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Percopo              CM, Rice              TA, Brenner              TA, Dyer              KD, Luo              JL,                Kanakabandi              K, Sturdevant              DE, Porcella              SF,                Domachowske              JB, Keicher              JD, Rosenberg              HF. 2015.            Immunobiotic <i>Lactobacillus<\/i> administered post-exposure            averts the lethal sequelae of respiratory virus infection.            Antiviral Res 121:            109\u2013119.","DOI":"10.1016\/j.antiviral.2015.07.001"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Rice              TA, Brenner              TA, Percopo              CM, Ma              M, Keicher              JD,                Domachowske              JB, Rosenberg              HF. 2016.            Signaling via pattern recognition receptors NOD2 and TLR2 contributes to            immunomodulatory control of lethal pneumovirus infection.            Antiviral Res 132:            131\u2013140.","DOI":"10.1016\/j.antiviral.2016.06.002"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. De Boeck              I, Wittouck              S, Wuyts              S, Oerlemans              EFM, van den                Broek              MFL,                Vandenheuvel              D,                Vanderveken              O, Lebeer              S. 2017.            Comparing the healthy nose and nasopharynx microbiota reveals continuity            as well as niche-specificity. Front Microbiol 8: 2372.","DOI":"10.3389\/fmicb.2017.02372"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Laufer              AS, Metlay              JP, Gent              JF, Fennie              KP, Kong              Y, Pettigrew              MM. 2011.            Microbial communities of the upper respiratory tract and otitis media in            children. MBio 2:            e00245\u2013e10.","DOI":"10.1128\/mBio.00245-10"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Pettigrew              MM, Laufer              AS, Gent              JF, Kong              Y, Fennie              KP, Metlay              JP. 2012.            Upper respiratory tract microbial communities, acute otitis media            pathogens, and antibiotic use in healthy and sick children. Appl            Environ Microbiol 78: 6262\u20136270.","DOI":"10.1128\/AEM.01051-12"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Camelo-Castillo              A, Henares              D, Brotons              P, Galiana              A, Rodr\u00edguez              JC, Mira              A,                Mu\u00f1oz-Almagro              C. 2019.            Nasopharyngeal microbiota in children with invasive pneumococcal disease:            identification of bacteria with potential disease-promoting and protective            effects. Front Microbiol 10:            11.","DOI":"10.3389\/fmicb.2019.00011"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Kanmani              P, Clua              P,                Vizoso-Pinto              MG, Rodriguez              C, Alvarez              S, Melnikov              V, Takahashi              H, Kitazawa              H, Villena              J. 2017.            Respiratory commensal bacteria <i>Corynebacterium              pseudodiphtheriticum<\/i> improves resistance of infant mice to Respiratory            Syncytial Virus and S<i>treptococcus pneumoniae<\/i>            superinfection. Front Microbiol 8:            1613.","DOI":"10.3389\/fmicb.2017.01613"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Wen              Z, Xie              G, Zhou              Q, Qiu              C, Li              J, Hu              Q, Dai              W, Li              D, Zheng              Y, Wen              F. 2018.            Distinct nasopharyngeal and oropharyngeal microbiota of children with            Influenza A virus compared with healthy children. BioMed Res            Int 2018: 6362716.","DOI":"10.1155\/2018\/6362716"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Ortiz Moyano              R, Raya                Tonetti              F, Tomokiyo              M, Kanmani              P,                Vizoso-Pinto              MG, Kim              H,                Quilodr\u00e1n-Vega              S, Melnikov              V, Alvarez              S, Takahashi              H, Kurata              S, Kitazawa              H, Villena              J. 2020.            The ability of respiratory commensal bacteria to beneficially modulate            the lung innate immune response is a strain dependent characteristic.            Microorganisms 8: 8.","DOI":"10.3390\/microorganisms8050727"},{"key":"58","doi-asserted-by":"crossref","unstructured":"59. Albarracin              L,                Garcia-Castillo              V, Masumizu              Y, Indo              Y, Islam              MA, Suda              Y,                Garcia-Cancino              A, Aso              H, Takahashi              H, Kitazawa              H, Villena              J. 2020.            Efficient selection of new immunobiotic strains with antiviral effects in            local and distal mucosal sites by using porcine intestinal            epitheliocytes. Front Immunol 11:            543.","DOI":"10.3389\/fimmu.2020.00543"},{"key":"59","doi-asserted-by":"crossref","unstructured":"60. Albarracin              L, Kobayashi              H, Iida              H, Sato              N, Nochi              T, Aso              H, Salva              S, Alvarez              S, Kitazawa              H, Villena              J. 2017.            Transcriptomic analysis of the innate antiviral immune response in            porcine intestinal epithelial cells: influence of immunobiotic            lactobacilli. Front Immunol 8:            57.","DOI":"10.3389\/fimmu.2017.00057"},{"key":"60","doi-asserted-by":"crossref","unstructured":"61. Villena              J,                Vizoso-Pinto              MG, Kitazawa              H. 2016.            Intestinal innate antiviral immunity and immunobiotics: beneficial            effects against Rotavirus infection. Front            Immunol 7: 563.","DOI":"10.3389\/fimmu.2016.00563"},{"key":"61","doi-asserted-by":"crossref","unstructured":"62. Le Bon              A, Tough              DF. 2002.            Links between innate and adaptive immunity via type I            interferon. Curr Opin Immunol 14:            432\u2013436.","DOI":"10.1016\/S0952-7915(02)00354-0"},{"key":"62","doi-asserted-by":"crossref","unstructured":"63. Montoya              M, Schiavoni              G, Mattei              F, Gresser              I, Belardelli              F, Borrow              P, Tough              DF. 2002.            Type I interferons produced by dendritic cells promote their phenotypic            and functional activation. Blood 99:            3263\u20133271.","DOI":"10.1182\/blood.V99.9.3263"},{"key":"63","doi-asserted-by":"crossref","unstructured":"64. Yoo              JK, Baker              DP, Fish              EN. 2010.            Interferon-\u03b2 modulates type 1 immunity during influenza virus            infection. Antiviral Res 88:            64\u201371.","DOI":"10.1016\/j.antiviral.2010.07.006"},{"key":"64","doi-asserted-by":"publisher","unstructured":"65. Le Bon              A, Schiavoni              G, D\u2019Agostino              G, Gresser              I, Belardelli              F, Tough              DF. 2001.            Type i interferons potently enhance humoral immunity and can promote            isotype switching by stimulating dendritic cells in vivo.            Immunity 14: 461\u2013470.","DOI":"10.1016\/S1074-7613(01)00126-1"},{"key":"65","doi-asserted-by":"crossref","unstructured":"66. Mostafa              HH, Fissel              JA, Fanelli              B, Bergman              Y,                Gniazdowski              V, Dadlani              M, Carroll              KC, Colwell              RR, Simner              PJ. 2020.            Metagenomic next-generation sequencing of nasopharyngeal specimens            collected from confirmed and suspect COVID-19 patients.            MBio 11: 11.","DOI":"10.1128\/mBio.01969-20"},{"key":"66","doi-asserted-by":"crossref","unstructured":"67. Sungnak              W, Huang              N, B\u00e9cavin              C, Berg              M, Queen              R,                Litvinukova              M,                Talavera-L\u00f3pez              C, Maatz              H, Reichart              D,                Sampaziotis              F, Worlock              KB, Yoshida              M, Barnes              JL, Banovich              N, Barbry              P, Brazma              A, Collin              J, Desai              T, Duong              T, Eickelberg              O, Falk              C, Farzan              M, Glass              I, Gupta              R, Haniffa              M, Horvath              P, Hubner              N, Hung              D, Kaminski              N, Krasnow              M, Kropski              J, Kuhnemund              M, Lako              M, Lee              H, Leroy              S, Linnarson              S, Lundeberg              J, Meyer              K, Miao              Z, Misharin              A, Nawijn              M, Nikolic              M, Noseda              M,                Ordovas-Montanes              J, Oudit              GY, Pe\u2019er              D, Powell              J, Quake              S, Rajagopal              J, Tata              P, Rawlins              E, Regev              A, Reyfman              P,                Rozenblatt-Rosen              O, Saeb-Parsy              K, Samakovlis              C, Schiller              H, Schultze              J, Seibold              M, Seidman              C, Seidman              J, Shalek              A, Shepherd              D, Spence              J, Spira              A, Sun              X, Teichmann              S, Theis              F, Tsankov              A, Vallier              L, van den                Berge              M, Whitsett              J, Xavier              R, Xu              Y, Zaragosi              L, Zerti              D, Zhang              H, Zhang              K, Rojas              M, Figueiredo              F, HCA Lung            Biological Network 2020. SARS-CoV-2 entry            factors are highly expressed in nasal epithelial cells together with innate immune            genes. Nat Med 26:            681\u2013687.","DOI":"10.1038\/s41591-020-0868-6"},{"key":"67","doi-asserted-by":"crossref","unstructured":"68. Smith              N, Goncalves              P, Charbit              B, Grzelak              L, Beretta              M, Planchais              C, Bruel              T, Rouilly              V, Bondet              V, Hadjadj              J, Yatim              N, Pere              H, Merkling              SH, Ghozlane              A, Kern\u00e9is              S,                Rieux-Laucat              F, Terrier              B, Schwartz              O, Mouquet              H, Duffy              D, Di Santo              JP. 2021.            Distinct systemic and mucosal immune responses during acute SARS-CoV-2            infection. Nat Immunol 22:            1428\u20131439.","DOI":"10.1038\/s41590-021-01028-7"},{"key":"68","doi-asserted-by":"crossref","unstructured":"69. Xiong              D, Muema              C, Zhang              X, Pan              X, Xiong              J, Yang              H, Yu              J, Wei              H. 2021.            Enriched opportunistic pathogens revealed by metagenomic sequencing hint            potential linkages between pharyngeal microbiota and COVID-19.            Virol Sin 36: 924\u2013933.","DOI":"10.1007\/s12250-021-00391-x"},{"key":"69","doi-asserted-by":"crossref","unstructured":"70. Hord              NG. 2008.            Eukaryotic-microbiota crosstalk: potential mechanisms for health benefits            of prebiotics and probiotics. Annu Rev Nutr 28: 215\u2013231.","DOI":"10.1146\/annurev.nutr.28.061807.155402"},{"key":"70","doi-asserted-by":"crossref","unstructured":"71. Ventero              MP, Cuadrat              RRC, Vidal              I, Andrade              BGN,                Molina-Pardines              C,                Haro-Moreno              JM, Coutinho              FH, Merino              E, Regitano              LCA, Silveira              CB, Afli              H,                L\u00f3pez-P\u00e9rez              M, Rodr\u00edguez              JC. 2021.            Nasopharyngeal microbial communities of patients infected with SARS-CoV-2            that developed COVID-19. Front Microbiol 12: 637430.","DOI":"10.3389\/fmicb.2021.637430"},{"key":"71","doi-asserted-by":"crossref","unstructured":"72. Merenstein              C, Liang              G, Whiteside              SA,                Cobi\u00e1n-G\u00fcemes              AG, Merlino              MS, Taylor              LJ, Glascock              A, Bittinger              K, Tanes              C,                Graham-Wooten              J, Khatib              LA,                Fitzgerald              AS, Reddy              S, Baxter              AE, Giles              JR, Oldridge              DA, Meyer              NJ, Wherry              EJ, McGinniss              JE, Bushman              FD, Collman              RG. 2021.            Signatures of COVID-19 Severity and immune response in the respiratory            tract microbiome. MBio 12:            e0177721.","DOI":"10.1128\/mBio.01777-21"},{"key":"72","doi-asserted-by":"crossref","unstructured":"73. Rattanaburi              S, Sawaswong              V,                Chitcharoen              S,                Sivapornnukul              P, Nimsamer              P,                Suntronwong              N, Puenpa              J, Poovorawan              Y, Payungporn              S. 2022.            Bacterial microbiota in upper respiratory tract of COVID-19 and influenza            patients. Exp Biol Med (Maywood) 247:            409\u2013415.","DOI":"10.1177\/15353702211057473"},{"key":"73","doi-asserted-by":"crossref","unstructured":"74. Larsen              JM. 2017.            The immune response to <i>Prevotella<\/i> bacteria in chronic            inflammatory disease. Immunology 151:            363\u2013374.","DOI":"10.1111\/imm.12760"},{"key":"74","doi-asserted-by":"crossref","unstructured":"75. Hotez              PJ, Bottazzi              ME, Corry              DB. 2020.            The potential role of Th17 immune responses in coronavirus            immunopathology and vaccine-induced immune enhancement. Microbes            Infect 22: 165\u2013167.","DOI":"10.1016\/j.micinf.2020.04.005"},{"key":"75","doi-asserted-by":"crossref","unstructured":"76. Adalbert              JR, Varshney              K, Tobin              R, Pajaro              R. 2021.            Clinical outcomes in patients co-infected with COVID-19 and              <i>Staphylococcus aureus<\/i>: a scoping review. BMC            Infect Dis 21: 985.","DOI":"10.1186\/s12879-021-06616-4"},{"key":"76","doi-asserted-by":"crossref","unstructured":"77. Cusumano              JA, Dupper              AC, Malik              Y, Gavioli              EM, Banga              J, Berbel                Caban              A, Nadkarni              D, Obla              A, Vasa              CV, Mazo              D, Altman              DR. 2020.              <i>Staphylococcus aureus<\/i> bacteremia in patients infected            with COVID-19: a case series. Open Forum Infect            Dis 7: ofaa518.","DOI":"10.1093\/ofid\/ofaa518"},{"key":"77","doi-asserted-by":"crossref","unstructured":"78. Leung              CH, Tseng              HK, Wang              WS, Chiang              HT, Wu              AY, Liu              CP. 2014.            Clinical characteristics of children and adults hospitalized for            influenza virus infection. J Microbiol Immunol            Infect 47: 518\u2013525.","DOI":"10.1016\/j.jmii.2013.06.002"},{"key":"78","doi-asserted-by":"publisher","unstructured":"79. Chertow              DS, Memoli              MJ. 2013.            Bacterial coinfection in influenza: a grand rounds          review. JAMA 309:            275\u2013282.","DOI":"10.1001\/jama.2012.194139"},{"key":"79","doi-asserted-by":"crossref","unstructured":"80. Hurst              J, McCumber              A, Aquino              J, Rodriguez              J, Heston              S, Lugo              D, Rotta              A, Turner              N, Pfeiffer              T, Gurley              T, Moody              M, Denny              T, Rawls              J, Woods              C, Kelly              M. 2021.            Age-related changes in the upper respiratory microbiome are associated            with SARS-CoV-2 susceptibility and illness            severity. medRxiv: 2021.2003.2020.21252680.","DOI":"10.1101\/2021.03.20.21252680"},{"key":"80","doi-asserted-by":"crossref","unstructured":"81. Jamilloux              Y, Henry              T, Belot              A, Viel              S, Fauter              M, El Jammal              T, Walzer              T, Fran\u00e7ois              B, S\u00e8ve              P. 2020.            Should we stimulate or suppress immune responses in COVID-19? Cytokine            and anti-cytokine interventions. Autoimmun Rev 19: 102567.","DOI":"10.1016\/j.autrev.2020.102567"},{"key":"81","doi-asserted-by":"crossref","unstructured":"82. Sun              J, Wang              J, Yuan              X, Wu              X, Sui              T, Wu              A, Cheng              G, Jiang              T. 2019.            Regulation of early host immune responses shapes the pathogenicity of            avian Influenza A Virus. Front Microbiol 10: 2007.","DOI":"10.3389\/fmicb.2019.02007"},{"key":"82","first-page":"10","volume":"10","year":"2021","unstructured":"83. Islam              MA,                Albarracin              L, Melnikov              V, Andrade              BGN, Cuadrat              RRC, Kitazawa              H, Villena              J. 2021.              <i>Dolosigranulum pigrum<\/i> modulates immunity against            SARS-CoV-2 in respiratory epithelial cells.            Pathogens 10: 10.","journal-title":"Pathogens","ISSN":"https:\/\/id.crossref.org\/issn\/2076-0817","issn-type":"print"},{"key":"83","doi-asserted-by":"crossref","unstructured":"84. De Maio              F, Posteraro              B, Ponziani              FR, Cattani              P, Gasbarrini              A,                Sanguinetti              M. 2020.            Nasopharyngeal microbiota profiling of SARS-CoV-2 infected            patients. Biol Proced Online 22:            18.","DOI":"10.1186\/s12575-020-00131-7"},{"key":"84","doi-asserted-by":"crossref","unstructured":"85. Lopu\u0161n\u00e1              K, Re\u017euchov\u00e1              I, Bet\u00e1kov\u00e1              T, Skovranov\u00e1              L, Toma\u0161kov\u00e1              J, Luk\u00e1\u010dikov\u00e1              L, Kab\u00e1t              P. 2013.            Interferons lambda, new cytokines with antiviral          activity. Acta Virol 57:            171\u2013179.","DOI":"10.4149\/av_2013_02_171"},{"key":"85","doi-asserted-by":"crossref","unstructured":"86. Felgenhauer              U, Schoen              A, Gad              HH, Hartmann              R, Schaubmar              AR, Failing              K, Drosten              C, Weber              F. 2020.            Inhibition of SARS-CoV-2 by type I and type III            interferons. J Biol Chem 295:            13958\u201313964.","DOI":"10.1074\/jbc.AC120.013788"},{"key":"86","doi-asserted-by":"crossref","unstructured":"87. Sun              J, Ye              F, Wu              A, Yang              R, Pan              M, Sheng              J, Zhu              W, Mao              L, Wang              M, Xia              Z, Huang              B, Tan              W, Jiang              T. 2020.            Comparative transcriptome analysis reveals the intensive early stage            responses of host cells to SARS-CoV-2 infection. Front            Microbiol 11: 593857.","DOI":"10.3389\/fmicb.2020.593857"},{"key":"87","doi-asserted-by":"crossref","unstructured":"88. Lokugamage              KG, Hage              A, de Vries              M,                Valero-Jimenez              AM,                Schindewolf              C, Dittmann              M, Rajsbaum              R, Menachery              VD. 2020.            Type I interferon susceptibility distinguishes SARS-CoV-2 from            SARS-CoV. J Virol 94:            94.","DOI":"10.1128\/JVI.01410-20"},{"key":"88","doi-asserted-by":"crossref","unstructured":"89. Schroeder              S, Pott              F, Niemeyer              D, Veith              T, Richter              A, Muth              D, Goffinet              C, M\u00fcller              MA, Drosten              C. 2021.            Interferon antagonism by SARS-CoV-2: a functional study using reverse            genetics. Lancet Microbe 2:            e210\u2013e218.","DOI":"10.1016\/S2666-5247(21)00027-6"},{"key":"89","doi-asserted-by":"publisher","unstructured":"90. Hadjadj              J, Yatim              N, Barnabei              L, Corneau              A, Boussier              J, Smith              N, P\u00e9r\u00e9              H, Charbit              B, Bondet              V,                Chenevier-Gobeaux              C, Breillat              P, Carlier              N, Gauzit              R, Morbieu              C, P\u00e8ne              F, Marin              N, Roche              N, Szwebel              TA, Merkling              SH, Treluyer              JM, Veyer              D, Mouthon              L, Blanc              C, Tharaux              PL, Rozenberg              F, Fischer              A, Duffy              D,                Rieux-Laucat              F, Kern\u00e9is              S, Terrier              B. 2020.            Impaired type I interferon activity and inflammatory responses in severe            COVID-19 patients. Science 369:            718\u2013724.","DOI":"10.1126\/science.abc6027"},{"key":"90","doi-asserted-by":"crossref","unstructured":"91. Arunachalam              PS, Wimmers              F, Mok              CKP, Perera              RAPM, Scott              M, Hagan              T, Sigal              N, Feng              Y, Bristow              L, Tak-Yin                Tsang              O, Wagh              D, Coller              J, Pellegrini              KL, Kazmin              D, Alaaeddine              G, Leung              WS, Chan              JMC, Chik              TSH, Choi              CYC, Huerta              C, Paine                McCullough              M, Lv              H, Anderson              E, Edupuganti              S, Upadhyay              AA, Bosinger              SE, Maecker              HT, Khatri              P, Rouphael              N, Peiris              M, Pulendran              B. 2020.            Systems biological assessment of immunity to mild versus severe COVID-19            infection in humans. Science 369:            1210\u20131220.","DOI":"10.1126\/science.abc6261"},{"key":"91","doi-asserted-by":"publisher","unstructured":"92. Blanco-Melo              D,                Nilsson-Payant              BE, Liu              WC, Uhl              S, Hoagland              D, M\u00f8ller              R, Jordan              TX, Oishi              K, Panis              M, Sachs              D, Wang              TT, Schwartz              RE, Lim              JK, Albrecht              RA, tenOever              BR. 2020.            Imbalanced host response to SARS-CoV-2 drives development of            COVID-19. Cell 181:          1036\u20131045.e9.","DOI":"10.1016\/j.cell.2020.04.026"},{"key":"92","doi-asserted-by":"crossref","unstructured":"93. Invernizzi              R, Lloyd              CM, Molyneaux              PL. 2020.            Respiratory microbiome and epithelial interactions shape immunity in the            lungs. Immunology 160:            171\u2013182.","DOI":"10.1111\/imm.13195"},{"key":"93","doi-asserted-by":"crossref","unstructured":"94. Tada              A, Zelaya              H, Clua              P, Salva              S, Alvarez              S, Kitazawa              H, Villena              J. 2016.            Immunobiotic <i>Lactobacillus<\/i> strains reduce small            intestinal injury induced by intraepithelial lymphocytes after Toll-like receptor 3            activation. Inflamm Res 65:            771\u2013783.","DOI":"10.1007\/s00011-016-0957-7"},{"key":"94","doi-asserted-by":"crossref","unstructured":"95. Clua              P, Kanmani              P, Zelaya              H, Tada              A, Kober              AKMH, Salva              S, Alvarez              S, Kitazawa              H, Villena              J. 2017.            Peptidoglycan from immunobiotic <i>Lactobacillus rhamnosus<\/i>            improves resistance of infant mice to respiratory syncytial viral infection and            secondary pneumococcal pneumonia. Front Immunol 8: 948.","DOI":"10.3389\/fimmu.2017.00948"},{"key":"95","doi-asserted-by":"crossref","unstructured":"96. Villena              J, Chiba              E,                Vizoso-Pinto              MG, Tomosada              Y, Takahashi              T, Ishizuka              T, Aso              H, Salva              S, Alvarez              S, Kitazawa              H. 2014.            Immunobiotic <i>Lactobacillus rhamnosus<\/i> strains            differentially modulate antiviral immune response in porcine intestinal epithelial and            antigen presenting cells. BMC Microbiol 14: 126.","DOI":"10.1186\/1471-2180-14-126"},{"key":"96","doi-asserted-by":"crossref","unstructured":"97. Villena              J, Kitazawa              H. 2020.            The modulation of mucosal antiviral immunity by immunobiotics: could they            offer any benefit in the SARS-CoV-2 pandemic? Front            Physiol 11: 699.","DOI":"10.3389\/fphys.2020.00699"},{"key":"97","doi-asserted-by":"crossref","unstructured":"98. Villena              J, Li              C,                Vizoso-Pinto              MG, Sacur              J, Ren              L, Kitazawa              H. 2021.              <i>Lactiplantibacillus plantarum<\/i> as a potential adjuvant            and delivery system for the development of SARS-CoV-2 oral vaccines.            Microorganisms 9: 9.","DOI":"10.3390\/microorganisms9040683"}],"container-title":["Bioscience of Microbiota, Food and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/41\/3\/41_2022-009\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:54:58Z","timestamp":1715234098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/41\/3\/41_2022-009\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.12938\/bmfh.2022-009","relation":{},"ISSN":["2186-3342"],"issn-type":[{"value":"2186-3342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"2022-009"}}